MedTrace Logo

Live Kidney Donor Study -Renal Function Study

NCT01158742 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 402

Last updated 2017-03-27

No results posted yet for this study

Summary

Kidney transplantation from living donors has been shown to carry many benefits over deceased donor transplantation. Because of benefits such as shorter waiting times and improved outcome for transplant recipients, living kidney donation accounts for an increasing number of kidney transplants nationwide. Most published studies about living kidney donation demonstrate that the procedure is safe, but they also emphasize concerns that long-term data on live donor outcomes are insufficient. In particular, data concerning the extent of renal function decline after donation are inadequate. This study will measure glomerular filtration rate (GFR) in previous living donors and aims to more accurately describe renal function after kidney donation.

Conditions

Interventions

OTHER

Glomerular Filtration Rate with Iothalamate

used to determine kidney function

OTHER

Glomerular Filtration Rate with Iohexol

used to determine kidney function

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Health Resources and Services Administration (HRSA)

    collaborator FED

  • National Institute of Allergy and Infectious Diseases (NIAID)

    lead NIH

Principal Investigators

  • Sandra J. Taler, MD · Mayo Clinic, Rochester, MN

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2012-06-30
Completion
2012-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01158742 on ClinicalTrials.gov